Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles

Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway

(2018) Mingxia Lu et al.   BIOMEDICINE & PHARMACOTHERAPY

Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21 Cip1/Waf1 , p27 Kip1 and cyclin D1

(2018) Karnika Singh et al.   CANCER LETTERS

Advances of blood cell-based drug delivery systems

(2017) Yanan Sun et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling

(2017) Yandong Lu et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery

(2016) Iliyas Khan et al.   CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy

(2016) Jin-Cherng Lien et al.   ENVIRONMENTAL TOXICOLOGY

A novel tetrandrine-loaded chitosan microsphere: characterization and in vivo evaluation

(2016) Jing Cang et al.   Drug Design Development and Therapy

Ginsenoside Rh2 differentially Mediates microRNA Expression to Prevent Chemoresistance of Breast Cancer

(2015) Xu Wen et al.   Asian Pacific Journal of Cancer Prevention

Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance

(2015) Lejiao Jia et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Cell or Cell Membrane-Based Drug Delivery Systems

(2015) Songwei Tan et al.   Theranostics

Coencapsulated Doxorubicin and Bromotetrandrine Lipid Nanoemulsions in Reversing Multidrug Resistance in Breast Cancer in Vitro and in Vivo

(2014) Xi Cao et al.   MOLECULAR PHARMACEUTICS

Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes

(2013) Weiwei Gao et al.   ADVANCED MATERIALS

Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies

(2013) Jiawei Li et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase

(2013) VIVIAN W.L. YU et al.   ONCOLOGY REPORTS

Enhanced Topical Delivery of Tetrandrine by Ethosomes for Treatment of Arthritis

(2013) Chao Fan et al.   Biomed Research International

Nanoparticles disguised as red blood cells to evade the immune system

(2012) Ronnie Hongbo Fang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line

(2012) Baoan Chen   International Journal of Nanomedicine

Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms

(2012) Ming-Xiang Ye et al.   PHYTOMEDICINE

Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein

(2011) Yinxu Zhang et al.   MEDICAL ONCOLOGY

Paclitaxel/Tetrandrine Coloaded Nanoparticles Effectively Promote the Apoptosis of Gastric Cancer Cells Based on “Oxidation Therapy”

(2011) Xiaolin Li et al.   MOLECULAR PHARMACEUTICS

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

(2011) Hirenkumar K. Makadia et al.   Polymers